October 2019 Published on: October 22, 2019 by Victoria Gacek Categories: Uncategorized Brilinta vs Effient in ACS Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction Death to Mortality as a Reported Percutaneous Coronary Intervention Quality Metric Inappropriate flouroquinalone prescriptions at discharge Rethinking oxygen therapy
